Latest news

14 Mar 2019 Breast
Genomic analysis re-classifies breast cancer into new subtypes
13 Mar 2019 Industry and business
AACR calls on Congress to reject Trump’s NIH budget proposal
11 Mar 2019 Breast
Tecentriq® gains accelerated US FDA approval for PD-L1-positive, triple-negative breast cancer
11 Mar 2019 Cancer biology and pathology
PARP inhibitors offer novel method for boosting immuno-oncology response

Video

View all videos

13 Feb 2019 Lung
Tumor clonality and resistance mechanisms in EGFR mutation-positive NSCLC: implications for therapeutic sequencing

Video

View all videos

Features

Stay up to date

Upcoming event

Gastrointestinal Cancers Symposium

January 17, 2019 – January 19, 2019

CA, USA

View all

Upcoming event

International Symposium on Focal Therapy and Imaging in Prostate and Kidney Cancer

February 9, 2019 – February 11, 2019

Kyoto, Japan

View all

Tweets

Oncology Central @OncologyCentral·

The latest #openaccess research published in @fsgfon suggests information from the ongoing #iooptimise initiative has potential to improve #lungcancer patient care. Find out how here: https://t.co/KpiEHKvpF6

View all

Jobs

Connecting talent with opportunity. View our featured jobs

View all

Our mission statement

At Oncology Central we are dedicated to advancing oncology by publishing trusted, engaging and insightful resources for the global oncology community.

Learn more

Genomic analysis re-classifies breast cancer into new subtypes

AACR calls on Congress to reject Trump’s NIH budget proposal

Tecentriq® gains accelerated US FDA approval for PD-L1-positive, triple-negative breast cancer

PARP inhibitors offer novel method for boosting immuno-oncology response

Pharma, President, Patients: the cancer cost conundrum

Exploring the Thyroid Imaging Reporting and Data System (TI-RADS): an interview with Franklin Tessler

Scientific and regulatory challenges in development of CAR-T therapy for solid tumors

Lung squamous cell carcinoma: key molecular player discovered

Colorectal cancer screening age to be lowered to 50 in England

Exploring the Thyroid Imaging Reporting and Data System (TI-RADS): an interview with Franklin Tessler

Q&A follow up: A closer look at physical activity and cancer prevention

A closer look at: physical activity and cancer prevention

Induction of receptor tyrosine kinase signaling by sera isolated from patients with lung adenocarcinoma

Video

Tumor clonality and resistance mechanisms in EGFR mutation-positive NSCLC: implications for therapeutic sequencing

Video

Login

Latest news

Genomic analysis re-classifies breast cancer into new subtypes

AACR calls on Congress to reject Trump’s NIH budget proposal

Tecentriq® gains accelerated US FDA approval for PD-L1-positive, triple-negative breast cancer

PARP inhibitors offer novel method for boosting immuno-oncology response

Featured articles

Pharma, President, Patients: the cancer cost conundrum

Exploring the Thyroid Imaging Reporting and Data System (TI-RADS): an interview with Franklin Tessler

Scientific and regulatory challenges in development of CAR-T therapy for solid tumors

Lung squamous cell carcinoma: key molecular player discovered

Colorectal cancer screening age to be lowered to 50 in England

Exploring the Thyroid Imaging Reporting and Data System (TI-RADS): an interview with Franklin Tessler

Q&A follow up: A closer look at physical activity and cancer prevention

A closer look at: physical activity and cancer prevention

Induction of receptor tyrosine kinase signaling by sera isolated from patients with lung adenocarcinoma

Video

Tumor clonality and resistance mechanisms in EGFR mutation-positive NSCLC: implications for therapeutic sequencing

Video

HTX-019 2-min injection shows promise as an alternative method of administration to prevent CINV

Unraveling the tumor biology of pancreatic cancer with Harpreet Wasan

Unraveling the tumor biology of pancreatic cancer with Harpreet Wasan

Emerging treatment options for pancreatic cancer with Thomas Seufferlein

Tamoxifen, SERMs and sustainable medicine

Seven challenges in immuno-oncology

Features

Interviews

Spotlights

Journal articles

Stay up to date

Oncology Central Newsletter